Found: 64
Select item for more details and to access through your institution.
Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cancer history and physical function in patients with cardiovascular disease.
- Published in:
- Heart & Vessels, 2024, v. 39, n. 7, p. 654, doi. 10.1007/s00380-024-02379-5
- By:
- Publication type:
- Article
Real-world data on the comprehensive genetic profiling test for Japanese patients with metastatic castration-resistant prostate cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 5, p. 569, doi. 10.1093/jjco/hyae003
- By:
- Publication type:
- Article
Phase II study of vinorelbine plus carboplatin with concurrent radiotherapy in elderly patients with non-small cell lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 3, p. 318, doi. 10.1093/jjco/hyz179
- By:
- Publication type:
- Article
The role of prophylactic cranial irradiation for patients with small-cell lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 1, p. 26, doi. 10.1093/jjco/hyx146
- By:
- Publication type:
- Article
Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Promoter DNA Hypermethylation of the Cysteine Dioxygenase 1 (CDO1) Gene in Intraductal Papillary Mucinous Neoplasm (IPMN).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 10, p. 4007, doi. 10.1245/s10434-020-08291-2
- By:
- Publication type:
- Article
Less demand on stem cell marker-positive cancer cells may characterize metastasis of colon cancer.
- Published in:
- PLoS ONE, 2023, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0277395
- By:
- Publication type:
- Article
Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinoma.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 1, p. 115, doi. 10.1007/s10637-023-01327-w
- By:
- Publication type:
- Article
First-line osimertinib for poor performance status patients with EGFR mutation-positive non-small cell lung cancer: A prospective observational study.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 430, doi. 10.1007/s10637-021-01195-2
- By:
- Publication type:
- Article
Real-world evaluation of second line chemotherapy for patients with advanced non-small cell lung cancer harboring preexisting interstitial lung disease.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 182, doi. 10.1007/s10637-021-01162-x
- By:
- Publication type:
- Article
Phase II study of amrubicin plus erlotinib in previously treated, advanced non-small cell lung cancer with wild-type epidermal growth factor receptor (TORG1320).
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 2, p. 530, doi. 10.1007/s10637-020-01031-z
- By:
- Publication type:
- Article
Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 6, p. 1906, doi. 10.1007/s10637-020-00948-9
- By:
- Publication type:
- Article
Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 3, p. 885, doi. 10.1007/s10637-020-00919-0
- By:
- Publication type:
- Article
Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 5, p. 642, doi. 10.1007/s10637-017-0482-8
- By:
- Publication type:
- Article
Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non–small cell lung cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 45, doi. 10.1007/s10637-017-0472-x
- By:
- Publication type:
- Article
Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non-Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non--Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol.
- Published in:
- Clinical Lung Cancer, 2016, v. 17, n. 1, p. 75, doi. 10.1016/j.cllc.2015.08.004
- By:
- Publication type:
- Article
Comparison of Bevacizumab Quantification Results in Plasma of Non-small Cell Lung Cancer Patients Using Bioanalytical Techniques Between LC-MS/MS, ELISA, and Microfluidic-based Immunoassay.
- Published in:
- AAPS Journal, 2019, v. 21, n. 6, p. N.PAG, doi. 10.1208/s12248-019-0369-z
- By:
- Publication type:
- Article
Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 1/2, p. 7, doi. 10.1159/000455147
- By:
- Publication type:
- Article
Clinical and Diagnostic Utility of Genomic Profiling for Digestive Cancers: Real-World Evidence from Japan.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1504, doi. 10.3390/cancers16081504
- By:
- Publication type:
- Article
Nitric Oxide Synthase Activity in Human Lung Cancer.
- Published in:
- Cancer Science, 1997, v. 88, n. 12, p. 1190, doi. 10.1111/j.1349-7006.1997.tb00348.x
- By:
- Publication type:
- Article
Evaluation of Amrubicin as a Third or Later Line of Chemotherapy for Advanced Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2013, v. 59, n. 2, p. 99, doi. 10.1159/000354207
- By:
- Publication type:
- Article
Pemetrexed for Previously Treated Patients with Non-Small Cell Lung Cancer and Differences in Efficacy according to Thymidylate Synthase Expression.
- Published in:
- Chemotherapy (0009-3157), 2012, v. 58, n. 4, p. 313, doi. 10.1159/000343048
- By:
- Publication type:
- Article
Safety and efficacy of carboplatin plus nab-paclitaxel for treating advanced non-small-cell lung cancer with interstitial lung disease.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 7, n. 4, p. 604, doi. 10.3892/mco.2017.1359
- By:
- Publication type:
- Article
Interstitial pneumonia following administration of pegfilgrastim during carboplatin and etoposide chemotherapy for small-cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Predictive significance of thyroid transcription factor-1 expression in patients with non-squamous non-small cell lung cancer with wild-type epidermal growth factor receptor treated with erlotinib.
- Published in:
- Molecular & Clinical Oncology, 2016, v. 5, n. 1, p. 14, doi. 10.3892/mco.2016.870
- By:
- Publication type:
- Article
Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx.
- Published in:
- International Journal of Cancer, 2000, v. 89, n. 2, p. 187, doi. 10.1002/(SICI)1097-0215(20000320)89:2<187::AID-IJC14>3.0.CO;2-V
- By:
- Publication type:
- Article
Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non‐small cell lung cancer prior to the approval of durvalumab.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 4, p. 1005, doi. 10.1111/1759-7714.13357
- By:
- Publication type:
- Article
Evaluation of osimertinib efficacy according to body surface area and body mass index in patients with non‐small cell lung cancer harboring an EGFR mutation: A prospective observational study.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 4, p. 880, doi. 10.1111/1759-7714.13018
- By:
- Publication type:
- Article
Questionnaire survey on patient awareness of invasive rebiopsy in advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 3, p. 501, doi. 10.1111/1759-7714.12964
- By:
- Publication type:
- Article
Amrubicin monotherapy for elderly patients with relapsed extensive‐disease small‐cell lung cancer: A retrospective study.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 10, p. 1279, doi. 10.1111/1759-7714.12833
- By:
- Publication type:
- Article
Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive‐disease small cell lung cancer in the elderly and patients with poor performance status.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 8, p. 967, doi. 10.1111/1759-7714.12772
- By:
- Publication type:
- Article
Evaluation of gefitinib efficacy according to body surface area in patients with non-small cell lung cancer harboring an EGFR mutation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 939, doi. 10.1007/s00280-014-2570-1
- By:
- Publication type:
- Article
Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1529, doi. 10.1007/s00280-012-1858-2
- By:
- Publication type:
- Article
Pneumothorax during Pemetrexed Treatment in a Patient with Non-Small Cell Lung Cancer: A Case Report and Literature Review.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Successful Chemotherapy with Nab-Paclitaxel in a Heavily Treated Non-Small Cell Lung Cancer Patient: A Case Report.
- Published in:
- Case Reports in Oncology, 2014, v. 7, n. 2, p. 401, doi. 10.1159/000364857
- By:
- Publication type:
- Article
Successful Chemotherapy with Carboplatin and S-1 for Thymic Carcinoma: A Case Report.
- Published in:
- Case Reports in Oncology, 2013, v. 6, n. 3, p. 526, doi. 10.1159/000356143
- By:
- Publication type:
- Article
A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 8695, doi. 10.2147/CMAR.S339891
- By:
- Publication type:
- Article
Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung Cancer.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 4911, doi. 10.2147/CMAR.S255552
- By:
- Publication type:
- Article
Impact of EGFR genotype on the efficacy of osimertinib in EGFR tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 4883, doi. 10.2147/CMAR.S207170
- By:
- Publication type:
- Article
Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung disease.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 7013, doi. 10.2147/CMAR.S189556
- By:
- Publication type:
- Article
Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 6039, doi. 10.2147/CMAR.S181789
- By:
- Publication type:
- Article
Rationale and protocol design of a phase II study of first-line osimertinib treatment for patients with poor performance status and EGFR mutation-positive non-small cell lung cancer (OPEN/TORG2040).
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10409-6
- By:
- Publication type:
- Article
The Glasgow Prognostic Score Predicts Survival Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer.
- Published in:
- Oncology, 2023, v. 101, n. 11, p. 695, doi. 10.1159/000532087
- By:
- Publication type:
- Article
The Glasgow Prognostic Score Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations Who Are Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors.
- Published in:
- Oncology, 2023, v. 101, n. 11, p. 685, doi. 10.1159/000530809
- By:
- Publication type:
- Article
The Glasgow Prognostic Score Predicts Outcomes of Pembrolizumab or Atezolizumab Monotherapy in Patients with Pretreated Non-Small Cell Lung Cancer.
- Published in:
- Oncology, 2023, v. 101, n. 1, p. 69, doi. 10.1159/000526964
- By:
- Publication type:
- Article
Smoking History as a Predictor of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer Harboring <bold>EGFR</bold> Mutations.
- Published in:
- Oncology, 2018, v. 95, n. 2, p. 109, doi. 10.1159/000488594
- By:
- Publication type:
- Article
Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status.
- Published in:
- Oncology, 2018, v. 94, n. 4, p. 207, doi. 10.1159/000486038
- By:
- Publication type:
- Article